BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11703291)

  • 1. A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Ramesh V; Sundar S
    Br J Dermatol; 2001 Oct; 145(4):630-2. PubMed ID: 11703291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid accurate field diagnosis of Indian visceral leishmaniasis.
    Sundar S; Reed SG; Singh VP; Kumar PC; Murray HW
    Lancet; 1998 Feb; 351(9102):563-5. PubMed ID: 9492776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
    J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant k39 antigen.
    Salotra P; Sreenivas G; Nasim AA; Subba Raju BV; Ramesh V
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):370-3. PubMed ID: 11874880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.
    Zijlstra EE; Nur Y; Desjeux P; Khalil EA; El-Hassan AM; Groen J
    Trop Med Int Health; 2001 Feb; 6(2):108-13. PubMed ID: 11251906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K39 strip test--easy, reliable and cost-effective field diagnosis for visceral leishmaniasis in India.
    Goswami RP; Bairagi B; Kundu PK
    J Assoc Physicians India; 2003 Aug; 51():759-61. PubMed ID: 14651134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
    Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis.
    Sundar S; Pai K; Sahu M; Kumar V; Murray HW
    Ann Trop Med Parasitol; 2002 Jan; 96(1):19-23. PubMed ID: 11989529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis.
    Salotra P; Raina A; Ramesh V
    Trans R Soc Trop Med Hyg; 1999; 93(1):98-101. PubMed ID: 10492802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of direct agglutination test based on promastigote and amastigote antigens for serodiagnosis of post-kala-azar dermal leishmaniasis.
    Singh R; Subba Raju BV; Jain RK; Salotra P
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1191-4. PubMed ID: 16210482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
    El Harith A; Chowdhury S; Al-Masum A; SemiĆ£o-Santos S; Das PK; Akhter S; Vetter JC; Haq I
    J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis.
    Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A
    Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody.
    Sundar S; Maurya R; Singh RK; Bharti K; Chakravarty J; Parekh A; Rai M; Kumar K; Murray HW
    J Clin Microbiol; 2006 Jan; 44(1):251-3. PubMed ID: 16390983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
    Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
    BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.
    Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
    Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.